14 search results for: lung function

<b>Lung</b> <b>Function</b> Decline: Why it Matters and What’s at Stake for Patients
Pulmonology
Lung Function Decline: Why it Matters and What’s at Stake for Patients
interactivity

Understand the drivers of lung function decline in chronic obstructive pulmonary disease (COPD), including chronic inflammation, key risk factors, and the impact on patient well-being .

View more
ADVENT On Air | Breathing Easy: Navigating <b>Lung</b> <b>Function</b> in Pediatric Severe Asthma With Spirometry and Beyond
Pulmonology
ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond
Podcast

Join Drs. Wanda Phipatanakul and Theresa Guilbert as they discuss the importance of routine lung function assessment in pediatric asthma patients.

View more
The Cycle of Inflammation in Adult Asthma
Pulmonology
The Cycle of Inflammation in Adult Asthma
interactivity

Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in patients with asthma.

View more
Uncovering the Impact of Moderate COPD Exacerbations
Pulmonology
Uncovering the Impact of Moderate COPD Exacerbations
interactivity

Understand the impact of moderate chronic obstructive pulmonary disease (COPD) exacerbations on future exacerbation risk, lung function decline, mortality, and patient quality of life.

View more
What Is The COPD Vicious Cycle?
Pulmonology
What Is The COPD Vicious Cycle?
expert video

Dr. Nicola Hanania explains the vicious cycle of exacerbations and lung function decline observed in COPD.

View more
World Lung Day 2024
Awareness Day
25
September
2024
Awareness Day
World Lung Day 2024

September 25th marks this year’s observance and celebration of World Lung Day!

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more
Eosinophils: A Biomarker in COPD
Pulmonology
Eosinophils: A Biomarker in COPD
Infographic

Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.

View more
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
Pulmonology
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

View more
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
Pulmonology
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
expert video

Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.

View more
What Differentiates COPD Exacerbations From Asthma Exacerbations?
Pulmonology
What Differentiates COPD Exacerbations From Asthma Exacerbations?
expert video

Join global expert Dr. Eric Bateman as he discusses how exacerbations in patients with COPD are different than exacerbations in patients with asthma.

View more
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age
Pulmonology
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age
interactivity

Explore GINA-based recommendations for identifying risk factors, optimizing management plans, and monitoring disease progression in pediatric asthma.

View more